Free Trial

What is Scotiabank's Estimate for Nutrien FY2026 Earnings?

Nutrien logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank cut its FY2026 EPS estimate for Nutrien to $4.33 from $4.62, slightly above the $4.27 analyst consensus. It forecasts FY2027 EPS of $4.48.
  • Nutrien’s latest quarter missed EPS expectations, reporting $0.61 per share versus $0.74 expected, while revenue of $5.69 billion narrowly beat forecasts and rose 0.9% year over year.
  • Analysts’ consensus rating is Moderate Buy, with a $79.19 average price target; the company also announced a quarterly dividend of $0.55 per share.
  • Five stocks we like better than Nutrien.

Nutrien Ltd. (NYSE:NTR - Free Report) - Investment analysts at Scotiabank cut their FY2026 earnings per share (EPS) estimates for Nutrien in a report issued on Wednesday, November 11th. Scotiabank analyst B. Isaacson now forecasts that the company will post earnings per share of $4.33 for the year, down from their prior forecast of $4.62. The consensus estimate for Nutrien's current full-year earnings is $4.27 per share. Scotiabank also issued estimates for Nutrien's FY2027 earnings at $4.48 EPS.

Other research analysts have also recently issued reports about the company. UBS Group raised their target price on Nutrien from $62.00 to $63.00 and gave the stock a "sell" rating in a research report on Thursday. Jefferies Financial Group reissued a "hold" rating and issued a $71.00 price target on shares of Nutrien in a report on Monday, October 12th. National Bank Financial dropped their price objective on shares of Nutrien from $76.00 to $74.00 and set an "outperform" rating for the company in a research note on Monday, August 10th. BNP Paribas Exane raised shares of Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 price objective for the company in a report on Tuesday, July 28th. Finally, Canadian Imperial Bank of Commerce reiterated an "outperform" rating on shares of Nutrien in a research report on Monday, August 10th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.19.

Get Our Latest Analysis on Nutrien

Nutrien Stock Performance

NTR opened at $71.32 on Monday. The stock has a market cap of $33.90 billion, a PE ratio of 15.57, a P/E/G ratio of 0.83 and a beta of 0.67. The company has a current ratio of 1.41, a quick ratio of 0.89 and a debt-to-equity ratio of 0.37. Nutrien has a 1 year low of $54.52 and a 1 year high of $85.36. The stock's 50 day simple moving average is $72.27 and its 200-day simple moving average is $71.16.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.13). Nutrien had a net margin of 7.78% and a return on equity of 8.00%. The firm had revenue of $5.69 billion for the quarter, compared to the consensus estimate of $5.66 billion. During the same quarter in the prior year, the firm earned $0.97 earnings per share. The company's revenue was up .9% on a year-over-year basis.

Institutional Investors Weigh In On Nutrien

Several hedge funds and other institutional investors have recently made changes to their positions in NTR. Jump Financial LLC bought a new stake in shares of Nutrien during the third quarter worth $386,000. Goehring & Rozencwajg Associates LLC lifted its stake in shares of Nutrien by 15.8% during the third quarter. Goehring & Rozencwajg Associates LLC now owns 1,684,602 shares of the company's stock valued at $118,343,000 after acquiring an additional 229,583 shares during the period. Pathstone Holdings LLC lifted its stake in shares of Nutrien by 31.8% during the third quarter. Pathstone Holdings LLC now owns 14,185 shares of the company's stock valued at $1,075,000 after acquiring an additional 3,425 shares during the period. Marshall Wace LLP boosted its holdings in Nutrien by 3.8% in the third quarter. Marshall Wace LLP now owns 27,800 shares of the company's stock valued at $1,953,000 after acquiring an additional 1,026 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Nutrien by 27.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,250,000 shares of the company's stock valued at $158,000,000 after acquiring an additional 486,744 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Thursday, December 31st will be given a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date is Thursday, December 31st. Nutrien's dividend payout ratio (DPR) is presently 48.03%.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a Canadian agricultural inputs and services company headquartered in Saskatoon, Saskatchewan. Formed in 2018 through the merger of Agrium and Potash Corporation of Saskatchewan, it serves farmers and other customers through fertilizer production and agricultural retail operations. The company produces potash, nitrogen and phosphate fertilizers, which are used to support crop growth. It also sells crop protection products and seeds, and provides growers with agronomic advice and other services.

Featured Articles

Earnings History and Estimates for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines